Mangoceuticals, Inc. Common Stock (MGRX)
Business numbers score is below the middle.
MGRX scores higher than 45% of the 653 tickers we compare it with (Consumer Discretionary).
As of 9 October 2026, Mangoceuticals, Inc. Common Stock (MGRX) scores 40 out of 100 on the Market Census six-factor composite, which puts it at the Average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 0.77× 30-day average
- 52-week range
- 0.16 – 2.75
- Market cap
- $10.27M
- Earnings date
- 12 Nov 2026
- Volume
- 433,609
- Avg. volume (30d)
- 565,904
- Open
- 0.44
- Previous close
- 0.43
- Day's range (regular session)
- 0.41 – 0.44
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
Premium data held for MGRX
- 5 SEC Form 4 insider transactions in the last 90 daysPremium
Counts of rows Market Census holds for MGRX. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans
What the score says about MGRX right now
Mangoceuticals, Inc. Common Stock (MGRX) currently scores 40/100 on the Market Census six-factor composite, at the Average score level. MGRX is -2.41% on the day and -3.45% over five sessions as of the most recent tick. Average sits in the middle. The good and the bad in MGRX's data roughly balance out right now. MGRX's strongest factor is strength vs the market at 59/100 — a fairly good read on how MGRX has done next to the wider market. It describes what has happened, not what happens next. The weakest factor is company finances at 0/100 — well below average company numbers. A low company-finances reading is the canonical "value trap" warning: technical setups on broken fundamentals don't tend to compound.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See MGRX in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent MGRX news
Latest headlines that name Mangoceuticals, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- Mangoceuticals (MGRX) Shares Fall 12% After Hours: Here's WhyBenzinga
- Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million TrancheGlobeNewswire Inc.
- Mangoceuticals’ MangoRx IP Secures $2.5M Investment From Strategic Investors, Receives Initial $1.75M TrancheBenzinga
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Consumer Discretionary right now
Six consumer discretionary tickers whose composite scores are closest to MGRX’s 40, all within 1 point.
Sorted by closeness to MGRX’s composite score within Consumer Discretionary. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.